• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.02
  • VXN 16.95
  • VXO 14.44
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional and diagnostic procedures worldwide. The company?s cardiology and radiology products include percutaneous coronary interventions and percutaneous peripheral interventions. Its inflation devices, such as IntelliSystem, Monarch, and Basix COMPAK are used for measuring pressures during balloon and stent deployment. Merit Medical offers hemostasis valves; vascular retrieval devices; vascular access products; and diagnostic catheters, guide wires, and torque devices. The company also offers angiography and angioplasty accessories used during minimally invasive diagnosis and for the treatment of coronary artery and peripheral disease; safety and waste management systems to help avoid accidental exposure to contaminated fluids; and drainage catheters and accessories for nephrostomy, abscess, and other drainage procedures. In addition, it offers paracentesis and pericardiocentesis catheters to provide clinicians with a safe and convenient alternative for paracentesis procedures; therapeutic infusion catheters for the treatment of thrombus formation in the peripheral vessels of the body; multipurpose microcatheters for the delivery of interventional devices or therapeutic pharmaceuticals into selected blood vessels; and products for dialysis and interventional nephrology. Further, the company offers obesity-related products; gastroenterology and pulmonary products, such as non-vascular stents and bi-polar probes; and specialty procedure products, such as discography products and pressure sensors. It offers its products primarily to radiologists, anesthesiologists, physiatrists, neurologists, nephrologists, vascular surgeons, thoracic surgeons, technicians, and nurses. Merit Medical sells its products through direct sales forces, distributors, OEM partners, custom packagers, and packers. The company was founded in 1987 and is based in South Jordan, Utah.

NO
     
MMSI (Merit Medical Systems Inc)
Last Trade 40.91 Date 2/15/2020
Change % 0.94 % Price Change 0.38
Open 40.61 52 Week High 63.64
High 40.995 52 Week Low 19.5
Low 40.26 Type stock
Volume 235792 Average Volume 793695
Prev Close 40.53 Stock Exchange NASDAQ
Bid 19.55 Ask 41.24
Bid Size 1 Ask Size 23
1st Yr Estimated EPS Growth 2.5693 2nd Yr Estimated EPS Growth 0.121
2 Years Forward Earning Yield 0.043 2 Years Forward PE Ratio 23.2443
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 17.1936 Book Value Yield 0.4203
Buy Back Yield CAPE Ratio 74.7727
Cash Return 0.0024 Cash Flow per Share 1.3223
Cash Flow Yield 0.0323 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield 0.0081 EV/EBIT 80.8382
EV/EBITDA 20.986 EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue 2.6237 EV / Pre Tax Income 122.7339
EV / Revenue 2.8293 EV / Total Asset 1.5581
Expected Dividend Growth Rate Free Cash Flow per Share -0.0561
Free Caash Flow Ratio Free Cash Flow Yield -0.0014
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield 0.0384 Forward PE Ratio 26.0417
Forward Return on Asset 0.0492 Forward Return on Equity 0.0913
Normalized PE Ratio 93.006654 Payout Ratio 0.0
PB Ratio 2.379368 PB Ratio 10 Year Growth 0.009726
PB Ratio 3 Year Growth 3.134194 Cash Ratio 3 Year Average 6595.4451
Price to Cash Flow Ratio 30.939627 PEG Payback 11.7275
PEG Ratio 2.2659 PE Ratio 123.969697
PE Ratio 10 Year Average 50.081626 PE Ratio 10 Year Growth 0.193001
PE Ratio 10 Year High 183.166667 PE Ratio 10 Year Low 17.772152
PE Ratio 1 Year Avg 73.211128 PE Ratio 1 Year High 123.969697
PE Ratio 1 Year Low 38.657143 PE Ratio 3 Year Avg 85.685187
PE Ratio 5 Year Avg 67.54247 PE Ratio 5 Year High 183.166667
PE Ratio 5 Year Low 26.644068 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 154.588183 Price Change 1 Month 1.123284
Price to Cash Ratio 60.527768 Price / EBITDA 17.641399
Price to Sales Ratio 2.378404 Price to Sales Ratio 10 Year Growth 0.02471
Price to Sales Ratio 3 Year Avg 2.949366 Price to Sales Ratio 5 Year Avg 67.54247
Sale per Share 17.2006 Sales Yield 0.4205
Sustainable Growth Rate 0.0201 Tangible Book Value per Share 2.5028
Tangible Book Value per Share 3 year Avg 4.5277 Tangible Book Value per Share 5 year Avg 3.8366
Total Asset per Share 31.9098 Total Yield
Working Capital per Share 5.2182 Working Capital per Share 3 Year Avg 4.5188
Working Capital per Share 5 Year Avg 3.8635 Beta 1.340595
12